Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib with Concurrent Radiotherapy in Elderly Esophageal Cancer
NCT02375581Phase 2Unknown
- Sponsor
- Hangzhou First People's Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of icotinib in esophageal cancer, sponsored by Hangzhou First People's Hospital. Status: unknown.
02
Drugs
icotinib
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02375581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02375581.